PharmaceuticalCompanies
List your company
Menu
Register entry

Zhejiang Ausun Pharmaceutical Co., Ltd.

Data as of · How to read this entry

Request a quoteClaim this profile
Registered sites
1
Active NDC listings
55
Live patents
0
Countries
1
Base
China
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Zhejiang Ausun Pharmaceutical Co., Ltd.No.5, Donghai 4th Avenue, Zhejiang Chemical Materials Base Linhai Zone, Taizhou, Zhejiang 317015, China (CHN)Active ingredient (API) manufacture3009065969421277322
Catalogue

Drug listings by form and route

55

55 active NDC listings: 55 bulk ingredient. By marketing category: BULK INGREDIENT 45, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING 10.

Dosage formNDCs
powder52
oil2
liquid1
RouteNDCs
Labeller name on the listingNDCs
zhejiang ausun pharmaceutical co., ltd.55
Catalogue

Marketed products

55
BrandGeneric nameForm / routeNDC
-APIXABANpowder76397-007BULK INGREDIENT
-APIXABANpowder76397-010BULK INGREDIENT
-Alectinib Hydrochloridepowder76397-055BULK INGREDIENT
-Avatrombopag Maleatepowder76397-037BULK INGREDIENT
-Avatrombopag Maleatepowder76397-038BULK INGREDIENT
-Avatrombopag maleatepowder76397-041BULK INGREDIENT
-Bimatoprostpowder76397-016BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Dapagliflozinpowder76397-059BULK INGREDIENT
-Dapagliflozinpowder76397-060BULK INGREDIENT
-EFINACONAZOLEpowder76397-006BULK INGREDIENT
-ENTECAVIRpowder76397-001BULK INGREDIENT
-Efinaconazolepowder76397-017BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Efinaconazolepowder76397-018BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Efinaconazolepowder76397-058BULK INGREDIENT
-FEBUXOSTAT HEMIHYDRATEpowder76397-005BULK INGREDIENT
-Febuxostat hemihydratepowder76397-022BULK INGREDIENT
-Ibrutinibpowder76397-052BULK INGREDIENT
-Imatinib mesylatepowder76397-046BULK INGREDIENT
-Ivacaftorpowder76397-061BULK INGREDIENT
-Latanoprostliquid76397-051BULK INGREDIENT
-Latanoprostene Bunodoil76397-029BULK INGREDIENT
-Latanoptrostoil76397-020BULK INGREDIENT
-Lenvatinib Besylatepowder76397-042BULK INGREDIENT
-Lubiprostonepowder76397-012BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Lubiprostonepowder76397-025BULK INGREDIENT
-Lumateperone Tosylatepowder76397-047BULK INGREDIENT
-MACITENTANpowder76397-044BULK INGREDIENT
-Macitentanpowder76397-014BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Maralixibat Chloridepowder76397-040BULK INGREDIENT
-Maralixibat Chloridepowder76397-053BULK INGREDIENT
-NEBIVOLOL HYDROCHLORIDEpowder76397-008BULK INGREDIENT
-NEBIVOLOL HYDROCHLORIDEpowder76397-009BULK INGREDIENT
-Olaparibpowder76397-043BULK INGREDIENT
-POSACONAZOLEpowder76397-002BULK INGREDIENT
-Palbociclibpowder76397-048BULK INGREDIENT
-Palbociclibpowder76397-049BULK INGREDIENT
-Pilocarpine hydrochloridepowder76397-036BULK INGREDIENT
-Pilocarpine hydrochloridepowder76397-054BULK INGREDIENT
-Posaconazolepowder76397-011BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Posaconazolepowder76397-023BULK INGREDIENT
-Posaconazolepowder76397-024BULK INGREDIENT
-Ramelteonpowder76397-021BULK INGREDIENT
-Ramelteonpowder76397-032BULK INGREDIENT
-Ramelteonpowder76397-050BULK INGREDIENT
-Ruxolitinib phosphatepowder76397-035BULK INGREDIENT
-Ruxolitinib phosphatepowder76397-045BULK INGREDIENT
-Sugammadex Sodiumpowder76397-030BULK INGREDIENT
-Sugammadex Sodiumpowder76397-033BULK INGREDIENT
-Sugammadex Sodiumpowder76397-034BULK INGREDIENT
-Tafluprostpowder76397-013BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Tasimelteonpowder76397-015BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Tasimelteonpowder76397-019BULK INGREDIENT
-Tofacitinib Citratepowder76397-026BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Tofacitinib Citratepowder76397-028BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Tofacitinib Citratepowder76397-057BULK INGREDIENT
Neighbours

Registered in the same town

12
Compare

Comparable companies in China

Enquiry

Common questions

Is Zhejiang Ausun Pharmaceutical Co., Ltd. FDA approved?
Zhejiang Ausun Pharmaceutical Co., Ltd. holds 1 FDA-registered establishment in China. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Zhejiang Ausun Pharmaceutical Co., Ltd.'s drugs manufactured?
The FDA register lists Taizhou. Registered operations: active ingredient (API) manufacture.
What drugs does Zhejiang Ausun Pharmaceutical Co., Ltd. make?
55 products are listed under Zhejiang Ausun Pharmaceutical Co., Ltd. in the openFDA NDC Directory, most often as powder; oil; liquid. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.